Results 121 to 130 of about 15,991 (171)

Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven^®) utilization at a large academic medical center. [PDF]

Ther Adv Cardiovasc Dis, 2020
Marsh K, Green D, Raco V, Papadopoulos J, Ahuja T.   +4 more
europepmc   +1 more source

Targeting platelet EPCR for better therapeutic factor VIIa activity. [PDF]

J Thromb Haemost, 2018
Gu SX, Lentz SR.
europepmc   +1 more source

Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding. [PDF]

Dose Response, 2020
Chang ZG, Chu X, Chen W, Hu JH, Gong JW, Liu DD, He Q, Feng Z, Xiao SR, Liu YL.   +9 more
europepmc   +1 more source

Thrombosis and recombinant factor VIIa [PDF]

Journal of Thrombosis and Haemostasis, 2004
openaire   +2 more sources

Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling.

Blood
Zelaya H, Grunz K, Nguyen TS, Habibi A, Witzler C, Reyda S, Gonzalez-Menendez I, Quintanilla-Martinez L, Bosmann M, Weiler H, Ruf W.   +10 more
europepmc   +1 more source

Allostery in Coagulation Factor VIIa Revealed by Ensemble Refinement of Crystallographic Structures. [PDF]

Biophys J, 2019
Sorensen AB, Madsen JJ, Frimurer TM, Overgaard MT, Gandhi PS, Persson E, Olsen OH.   +6 more
europepmc   +1 more source

Life-Threatening Pulmonary Hemorrhage Responds to Recombinant Factor VIIa: A Case Series in South Florida Hospitals. [PDF]

Cureus, 2019
Diaz R, Almeida P, Alvarez M, Ferrer G, Hernandez F.   +4 more
europepmc   +1 more source

Correction to: Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia. [PDF]

Ann Hematol, 2018
Tiede A, Worster A.
europepmc   +1 more source